
Inovia Bio Insights
Keep Up To Date With All Things Inovia Bio &
Drug Development


How will FDA’s new AI draft guidance impact Drug Development?

The EMA vs Single-Arm Trials: 10 Lessons from the EMA Reflection Paper For Drug Developers

The AI Paradox in Pharma: Hype vs Reality - A Technical Insight

Bristol-Myers Squibb’s Acquisition of Celgene: A 5-Year Retrospective – Success, Synergies, and Strategic Growth

The single tactic every clinical development & Integrated evidence plan should have

The Most Underutilised Tool In Drug Development: Five Reasons To Start An Integrated Evidence Plan

How the IRA will impact Drug Development - Analysis Report

FDA Guidance on External Control Arms: A Checklist For Drug Developers
